Automating Amazing Charts Humira Prior Authorization

Humira PA Flow within Amazing Charts: Order Entry to Submission

When a provider initiates an order for Humira within Amazing Charts, Klivira's platform intercepts this request. Leveraging Amazing Charts APIs, our system automatically identifies the need for prior authorization. This eliminates the manual step of identifying PA requirements, triggering the ePA process for both medical and pharmacy benefit claims, irrespective of whether the payer requires an X12 278 or NCPDP SCRIPT transaction.

Automated Data Extraction for Adalimumab Medical Necessity

Klivira intelligently extracts relevant clinical data from Amazing Charts to support Humira prior authorizations. This includes pulling diagnostic codes from the problem list (e.g., rheumatoid arthritis, Crohn's disease, psoriasis, ulcerative colitis), documented medication history, and details on previous treatment failures from progress notes. Our system compiles this evidence to construct a robust case for medical necessity, aligning with payer-specific coverage criteria for TNF-alpha inhibitors.

Navigating Biosimilar Step Therapy and Specialty Pharmacy Routing

A common challenge with adalimumab PAs involves biosimilar step therapy requirements. Klivira's logic is configured to address these payer mandates, guiding the PA process through the necessary steps. Furthermore, for specialty drugs like Humira, appropriate specialty pharmacy routing is critical. Our platform assists in identifying and facilitating the correct pharmacy channel, ensuring continuity of care and avoiding delays in medication access for patients.

Addressing Medical vs. Pharmacy Benefit for TNF-alpha Inhibitors

Humira can fall under either the medical or pharmacy benefit depending on the payer and administration setting. Amazing Charts users often face complexity in determining the correct pathway. Klivira automatically discerns the appropriate benefit type and initiates the corresponding ePA workflow, whether it's a medical benefit claim requiring X12 278 or a pharmacy benefit claim via NCPDP SCRIPT, ensuring accurate and compliant submission every time.

Key Benefits for Amazing Charts Users Managing Humira PAs

• Reduced manual data entry and administrative burden for prior authorization coordinators.
• Accelerated turnaround times for Humira approvals through automated ePA submissions.
• Improved accuracy in documentation, leading to higher initial approval rates for adalimumab.
• Streamlined compliance with payer-specific requirements, including biosimilar step therapy.
• Enhanced visibility into PA status directly from the Amazing Charts workflow.